NCT00030615: Decitabine in Treating Patients With Advanced Solid Tumors |
|
|
| Completed | 1 | 24 | US | decitabine, 5-aza-dCyd, 5AZA, DAC, pharmacological study, pharmacological studies, laboratory biomarker analysis | National Cancer Institute (NCI) | Male Breast Cancer, Recurrent Bladder Cancer, Recurrent Breast Cancer, Recurrent Melanoma, Stage III Melanoma, Stage IV Bladder Cancer, Stage IV Breast Cancer, Stage IV Melanoma, Unspecified Adult Solid Tumor, Protocol Specific | 09/08 | | | |
